FindTrial
Sign In

Efficacy of Mansyadi Kwath in the Management of Hypertension

Efficacy of Ayurvedic Formulation (Mansyadi Kwath) in the Management of Hypertension (Uccha Raktachapa): A Randomised Open Clinical Trial - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093736
Enrollment
80
Registered
2025-08-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Sponsors

Dr SANJAY YADAV
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Essential Hypertensive patients having systolic blood pressure less then 160 and diastolic blood pressure less than 100 mmHg.

Exclusion criteria

Exclusion criteria: Hypertension with IHD, CHD, CAD, Coarctationof aorta, Renal failure, Endocrine diseases, Cerebral complications e.g. hypertensive encephalopathy, cerebral haemorrhage, convulsive seizure. Hypertensive patient having systolic blood pressure more than 160 and diastolic more than 100 mmHg. Pregnant lady.

Design outcomes

Primary

MeasureTime frame
Treatment with Mansyadi Kwath may result in a significant reduction in blood pressure, with an expected fall of 10?15 mmHg in mean value of systolic BP and 5?10 mmHg in mean value of diastolic BP, indicating potential clinical benefit in hypertension management.Timepoint: BP will be assessed on 1st and 30th day.—

Countries

India

Contacts

Public ContactDr SANJAY YADAV

Major S.D. Singh P.G. Ayurvedic Medical College and Hospital

8840026016ankit@gmail.com8840026016

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026